“A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report”. Journal of Pharma Insights and Research, vol. 4, no. 2, Apr. 2026, pp. 252-8, https://doi.org/10.69613/ss2yp015.